12 High-Growth Micro-Cap Stocks to Buy Now
Over the past few years, focus has been on large-cap stocks and the magnificent seven that have delivered spectacular returns.
Armata Pharmaceuticals Inc. (ARMP)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Millennium Management Israel Englander | 470,500 | $3,048,840 | +83% | 0% |
| 2. | Renaissance Technologies Jim Simons | 48,318 | $313,101 | +26% | 0% |
| 3. | Hudson Bay Capital Management Sander Gerber | 17,584 | $113,944 | 0% | |
| 4. | 683 Capital Partners Ari Zweiman | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $5.00 | 5,385,208 | $26,926,040.00 | 16,365,969 | 2022-03-31 | Filing | |
| $5.00 | 3,614,792 | $18,073,960.00 | 10,980,761 | 2022-02-09 | Filing | |
| $3.30 | 1,212,122 | $4,000,002.60 | 7,365,969 | 2021-10-29 | Filing | |
| $3.25 | 4,285,935 | $13,929,288.75 | 6,153,847 | 2021-03-17 | Filing | |
| $3.25 | 1,867,912 | $6,070,714.00 | 1,867,912 | 2021-01-26 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.45 | 20,077 | $9,034.65 | 674,169 | 2016-12-29 | Filing | |
| $0.47 | 40,450 | $19,011.50 | 694,246 | 2016-12-28 | Filing | |
| $0.51 | 24,092 | $12,286.92 | 734,696 | 2016-12-27 | Filing | |
| $0.45 | 21,923 | $9,865.35 | 736,170 | 2016-12-29 | Filing | |
| $0.47 | 44,170 | $20,759.90 | 758,093 | 2016-12-28 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 2,107,175 | $13,654,494 | 0.16% | |
| 2. | 559,986 | $3,628,710 | 0% | |
| 3. | 487,968 | $3,162,033 | 0% | |
| 4. | 270,550 | $1,753,791 | 0% | |
| 5. | 203,891 | $1,321,214 | 1.04% |
News See All
12 Most Promising Small-Cap Stocks According to Wall Street Analysts
Small-cap stocks are drawing renewed investor attention in 2026 as capital rotates away from years of concentration in mega-cap names.
Is Armata Pharmaceuticals, Inc. (ARMP) A Good Stock To Buy?
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first.
Hedge Fund Resource Center